EFFECT OF LIRAGLUTIDE ON CARDIOVASCULAR OUTCOMES IN ELDERLY PATIENTS IN THE LEADER TRIAL

被引：4
|
作者：
Gilbert, Matthew [1 ]
Bain, Stephen [1 ]
Franek, Edward [1 ]
Jodar-Gimeno, Esteban [1 ]
Nauck, Michael [1 ]
Pratley, Richard [1 ]
Rea, Rosangela [1 ]
Saraiva, Jose [1 ]
Rasmussen, Soren [1 ]
Tornoe, Karen [1 ]
von Scholten, Bernt Johan [1 ]
Buse, John B. [1 ]
机构：
[1] Novo Nordisk AS, Soborg, Denmark
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 11期
关键词：
D O I：
10.1016/S0735-1097(18)32259-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A1718
引用
收藏
页码：1718 / 1718
页数：1
相关论文
共 50 条
  • [1] Effect of liraglutide on cardiovascular outcomes in elderly patients in the LEADER trial
    Gilbert, M. P.
    Bain, S. C.
    Franek, E.
    Jodar-Gimeno, E.
    Nauck, M. A.
    Pratley, R. E.
    Rea, R.
    Saraiva, J.
    Rasmussen, S.
    Tornoe, K.
    von Scholten, B.
    Buse, J.
    DIABETOLOGIA, 2018, 61 : S368 - S369
  • [2] Effect of Liraglutide on Cardiovascular Outcomes in Elderly Patients: A Post Hoc Analysis of a Randomized Controlled Trial
    Gilbert, Matthew P.
    Bain, Stephen C.
    Franek, Edward
    Jodar-Gimeno, Esteban
    Nauck, Michael A.
    Pratley, Richard
    Rea, Rosangela Roginski
    Kerr Saraiva, Jose Francisco
    Rasmussen, Soren
    Tornoe, Karen
    von Scholten, Bernt Johan
    Buse, John B.
    Nauck, Michael A.
    Bain, Stephen C.
    Pratley, Richard
    Marso, Steven
    Zinman, Bernard
    Nissen, Steven
    Poulter, Neil
    Mann, Johannes
    Baeres, Florian M. M.
    ANNALS OF INTERNAL MEDICINE, 2019, 170 (06) : 423 - +
  • [3] Liraglutide and Glycaemic Outcomes in the LEADER Trial
    Zinman, Bernard
    Nauck, Michael A.
    Bosch-Traberg, Heidrun
    Frimer-Larsen, Helle
    Orsted, David D.
    Buse, John B.
    DIABETES THERAPY, 2018, 9 (06) : 2383 - 2392
  • [4] Effect of liraglutide on cardiovascular outcomes in patients with or without prior heart failure history in LEADER
    Saevereid, H. A.
    Husain, M.
    Bain, S. C.
    Mann, J. F. E.
    Nauck, M. A.
    Poulter, N.
    Goldman, B.
    Thomsen, A. B.
    Marso, S.
    DIABETOLOGIA, 2018, 61 : S564 - S565
  • [5] Liraglutide and Glycaemic Outcomes in the LEADER Trial
    Bernard Zinman
    Michael A. Nauck
    Heidrun Bosch-Traberg
    Helle Frimer-Larsen
    David D. Ørsted
    John B. Buse
    Diabetes Therapy, 2018, 9 : 2383 - 2392
  • [6] Liraglutide and renal outcomes in Type 2 diabetes: results of the 'Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results' (LEADER) trial
    Poulter, N.
    Mann, J. F. E.
    Brown-Frandsen, K.
    Daniels, G. H.
    Kristensen, P.
    Nauck, M. A.
    Nissen, S. E.
    Pocock, S.
    Buse, J. B.
    Petrie, J.
    DIABETIC MEDICINE, 2017, 34 : 23 - 24
  • [7] Cardiovascular outcomes in patients who experienced a myocardial infarction while treated with liraglutide versus placebo in the LEADER trial
    Nauck, Michael A.
    Tornoe, Karen
    Rasmussen, Soren
    Treppendahl, Marianne Bach
    Marso, Steven P.
    DIABETES & VASCULAR DISEASE RESEARCH, 2018, 15 (05): : 465 - 468
  • [8] Severe hypoglycaemia, cardiovascular outcomes and death: Experience from the 'Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results' (LEADER) trial
    Bain, S.
    Zinman, B.
    Marso, S. P.
    Christiansen, E.
    Calanna, S.
    Rasmussen, S.
    Buse, J. B.
    DIABETIC MEDICINE, 2018, 35 : 11 - 11
  • [9] Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease Results of the LEADER Trial
    Verma, Subodh
    Bhatt, Deepak L.
    Bain, Stephen C.
    Buse, John B.
    Mann, Johannes F. E.
    Marso, Steven P.
    Nauck, Michael A.
    Poulter, Neil R.
    Pratley, Richard E.
    Zinman, Bernard
    Michelsen, Marie M.
    Fries, Tea Monk
    Rasmussen, Soren
    Leiter, Lawrence A.
    CIRCULATION, 2018, 137 (20) : 2179 - 2183
  • [10] Follow the LEADER—Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial
    Sanjay Kalra
    Diabetes Therapy, 2016, 7 : 601 - 609
12345